AI-generated summary
The authors report a systematic review of studies on photobiomodulation therapy for Bell's palsy, published from 1993 to 2022, involving 21 to 120 participants per study. They report improvements in facial muscle function, pain intensity and muscle strength compared with control groups. The authors note heterogeneity in study designs and parameters and call for standardized randomized controlled trials.
- Who or what was studied
- Adults aged 18 to 70 with Bell's palsy, in studies involving 21 to 120 participants each
- Wavelengths
- 830, 850, 808, 905 nm
- Limits stated in the abstract
- The authors note heterogeneity in study designs, PBMT parameters and outcome measures, and call for further standardized, well-designed randomized controlled trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830-850 nm, 905 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review, Heterogeneity, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.